Barrett & Company Inc. Sells 750 Shares of Danaher Co. (NYSE:DHR)

Barrett & Company Inc. decreased its holdings in shares of Danaher Co. (NYSE:DHR) by 73.9% in the fourth quarter, Holdings Channel.com reports. The firm owned 265 shares of the conglomerate’s stock after selling 750 shares during the period. Barrett & Company Inc.’s holdings in Danaher were worth $61,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. AMF Tjanstepension AB purchased a new position in Danaher during the third quarter valued at $5,923,000. Miracle Mile Advisors LLC bought a new position in shares of Danaher during the third quarter valued at $310,000. Brookstone Capital Management boosted its stake in Danaher by 7.0% in the 3rd quarter. Brookstone Capital Management now owns 11,048 shares of the conglomerate’s stock worth $3,071,000 after purchasing an additional 720 shares in the last quarter. First PREMIER Bank grew its position in Danaher by 750.0% during the 3rd quarter. First PREMIER Bank now owns 340 shares of the conglomerate’s stock valued at $95,000 after purchasing an additional 300 shares during the last quarter. Finally, CWM LLC increased its stake in Danaher by 0.5% during the 3rd quarter. CWM LLC now owns 23,159 shares of the conglomerate’s stock valued at $6,439,000 after purchasing an additional 125 shares in the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 10.90% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the stock. JPMorgan Chase & Co. cut their price target on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Jefferies Financial Group reduced their target price on Danaher from $285.00 to $260.00 and set a “buy” rating for the company in a report on Wednesday, January 29th. TD Cowen upped their price target on Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price for the company in a research report on Thursday, October 31st. Finally, Stephens reaffirmed an “overweight” rating and set a $315.00 price target on shares of Danaher in a report on Wednesday, October 23rd. Seven equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, Danaher currently has an average rating of “Moderate Buy” and an average price target of $278.00.

Danaher Stock Performance

NYSE DHR opened at $209.95 on Friday. The stock has a market capitalization of $151.64 billion, a PE ratio of 39.76, a P/E/G ratio of 2.80 and a beta of 0.83. Danaher Co. has a 1-year low of $209.10 and a 1-year high of $281.70. The business has a 50 day simple moving average of $233.38 and a two-hundred day simple moving average of $252.10. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05.

Danaher (NYSE:DHR) last posted its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period last year, the firm earned $2.09 earnings per share. On average, research analysts predict that Danaher Co. will post 7.77 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Friday, December 27th were issued a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.51%. The ex-dividend date of this dividend was Friday, December 27th. Danaher’s payout ratio is 20.45%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.